Global /South Korea /Healthcare /Drug Manufacturers - General /303810

DK Life Science Co., Ltd.

303810

• KRX: 303810 • Delayed

3,460KRW -1.1%

2.29 USD

As of 18 June 2026, DK Life Science Co., Ltd. has a market cap of $74.16M USD, ranking #27755 globally and #1441 in South Korea. It ranks #2504 in the Healthcare sector, and #902 in the Drug Manufacturers - General industry.

Global Rank

27755

Country Rank

1441

Sector Rank

2504

Industry Rank

902

Key Stats

Market Cap

$74.16MUSD

111.94B KRW

Enterprise Value

$95.19MUSD

143.67B KRW

Revenue (TTM)

$86.35MUSD

130.34B KRW

EBITDA (TTM)

$12.89MUSD

19.46B KRW

Net Income (TTM)

$5.74MUSD

8.66B KRW

EBITDA Margin

15%

Profit Margin

6.6%

PE Ratio

12.7

PS Ratio

0.9

PB Ratio

0.9

EV/EBITDA

7.4

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Jae Won Park open_in_new

Employees

100

Founded

2017

Website

dkls.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.1%	2.2%	2.5%	-1.4%	-10%	-4.4%	-29%	-54%	-54%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	303810 동국생명과학(주) ISIN: KR7303810006 Shares Out.: Shares Outstanding: 31.984M¹ Shares Float: 10.219M² TV: TradingView: KRX: 303810 SA: Stock Analysis: KRX: 303810 YF: Yahoo Finance: 303810.KS GF: Google Finance: KRX: 303810 BA: Barron's: 303810 MS: Morningstar: XKRX: 303810	3,460 KRW	TV: TradingView: KRX: 303810 SA: Stock Analysis: KRX: 303810 YF: Yahoo Finance: 303810.KS GF: Google Finance: KRX: 303810 BA: Barron's: 303810 MS: Morningstar: XKRX: 303810

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About DK Life Science Co., Ltd.

DK Life Science Co., Ltd., a pharmaceutical company, develops and sells diagnostic medicines and medical devices in South Korea and internationally. It offers active pharmaceutical ingredients (API), injections, blood glucose self-monitoring device, Mobile CT equipment, and ultrasonic instruments. The company also offers catheters, MRI, CT scanner, ultrasound, mobile CT scanner, and X-ray equipment, as well as mammography image analysis assistance software. DK Life Science Co., Ltd. was founded in 2017 and is based in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.22B 13.91T KRW 12K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.83B 10.3T KRW 9K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.28B 7.97T KRW 7K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$5.0B 7.55T KRW 7K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.58B 6.92T KRW 6K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.48B 6.76T KRW 6K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 1M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 738K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 486K%	97.4	United States
Roche Holding AG SIX: RO	$323.08B 256.25B CHF 436K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.5B 215.59B GBP 390K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$275.99B 218.9B CHF 372K%	20.5	Switzerland

chevron_leftBack